Skip to main content

Alzheimer's Disease, Dementia & Cognitive Disorders

An Alzheimer's vaccine developed by a privately held Slovakian biotech firm showed early signs of efficacy in a mid-stage trial, a rare step forward in the fight against the brain-wasting disease, the company said.
Researchers at the Massachusetts Institute of Technology (MIT) have developed a machine-learning model they say can predict whether people at risk for Alzheimer’s disease will experience clinically significant cognitive decline within the next 2 years.
A test that measures levels of amyloid beta in the blood, when factored with a person’s age and the presence of the genetic variant APOE4, can identify brain changes from early Alzheimer’s disease with 94% accuracy, according to a study published online in Neurology.
Karl Doghramji, MD, Medical Director of the Jefferson Sleep Disorders Center in Philadelphia shares tips for choosing insomnia treatments for older patients with dementia.
Adults who reported declining sleep quality in their 40s and 50s had more beta-amyloid protein in their brains later in life, positron emission tomography brain scans revealed.
Back to Top